ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/20 | 2,919 | 2,979 | 2,914 | 2,971 | +38 | +1.3% | 178,700 |
2020/08/19 | 2,909 | 2,936 | 2,900 | 2,933 | +18 | +0.6% | 85,800 |
2020/08/18 | 2,900 | 2,930 | 2,877 | 2,915 | +34 | +1.2% | 100,300 |
2020/08/17 | 2,903 | 2,910 | 2,877 | 2,881 | -32 | -1.1% | 77,500 |
2020/08/14 | 2,943 | 2,943 | 2,912 | 2,913 | -59 | -2% | 128,500 |
2020/08/13 | 2,983 | 2,985 | 2,942 | 2,972 | +48 | +1.6% | 205,400 |
2020/08/12 | 2,890 | 2,946 | 2,862 | 2,924 | +33 | +1.1% | 169,800 |
2020/08/11 | 2,870 | 2,895 | 2,847 | 2,891 | +36 | +1.3% | 138,300 |
2020/08/07 | 2,925 | 2,984 | 2,853 | 2,855 | -45 | -1.6% | 260,800 |
2020/08/06 | 2,863 | 2,902 | 2,802 | 2,900 | +162 | +5.9% | 356,800 |
2020/08/05 | 2,728 | 2,758 | 2,695 | 2,738 | +10 | +0.4% | 167,200 |
2020/08/04 | 2,727 | 2,766 | 2,716 | 2,728 | +25 | +0.9% | 134,200 |
2020/08/03 | 2,679 | 2,714 | 2,660 | 2,703 | +72 | +2.7% | 99,500 |
2020/07/31 | 2,701 | 2,716 | 2,630 | 2,631 | -96 | -3.5% | 132,200 |
2020/07/30 | 2,734 | 2,755 | 2,721 | 2,727 | -3 | -0.1% | 113,700 |
2020/07/29 | 2,729 | 2,740 | 2,701 | 2,730 | ±0 | ±0% | 218,100 |
2020/07/28 | 2,760 | 2,777 | 2,721 | 2,730 | -24 | -0.9% | 132,300 |
2020/07/27 | 2,753 | 2,758 | 2,720 | 2,754 | -56 | -2% | 224,500 |
2020/07/22 | 2,766 | 2,840 | 2,757 | 2,810 | +52 | +1.9% | 280,300 |
2020/07/21 | 2,766 | 2,768 | 2,744 | 2,758 | -7 | -0.3% | 142,700 |
2020/07/20 | 2,754 | 2,768 | 2,738 | 2,765 | +27 | +1% | 111,400 |
2020/07/17 | 2,747 | 2,758 | 2,713 | 2,738 | +2 | +0.1% | 225,300 |
2020/07/16 | 2,774 | 2,782 | 2,728 | 2,736 | -46 | -1.7% | 154,100 |
2020/07/15 | 2,794 | 2,800 | 2,759 | 2,782 | +3 | +0.1% | 218,700 |
2020/07/14 | 2,829 | 2,829 | 2,779 | 2,779 | -38 | -1.3% | 85,500 |
2020/07/13 | 2,787 | 2,824 | 2,768 | 2,817 | +59 | +2.1% | 102,700 |
2020/07/10 | 2,760 | 2,787 | 2,754 | 2,758 | -1 | ±0% | 248,500 |
2020/07/09 | 2,740 | 2,778 | 2,713 | 2,759 | +12 | +0.4% | 159,800 |
2020/07/08 | 2,780 | 2,823 | 2,746 | 2,747 | -11 | -0.4% | 238,700 |
2020/07/07 | 2,770 | 2,770 | 2,731 | 2,758 | -47 | -1.7% | 206,200 |
2020/07/06 | 2,795 | 2,826 | 2,788 | 2,805 | +25 | +0.9% | 137,100 |
2020/07/03 | 2,795 | 2,796 | 2,761 | 2,780 | +8 | +0.3% | 121,900 |
2020/07/02 | 2,743 | 2,808 | 2,743 | 2,772 | +56 | +2.1% | 281,700 |
2020/07/01 | 2,821 | 2,839 | 2,709 | 2,716 | -104 | -3.7% | 206,900 |
2020/06/30 | 2,850 | 2,859 | 2,817 | 2,820 | -23 | -0.8% | 156,000 |
2020/06/29 | 2,850 | 2,864 | 2,838 | 2,843 | -39 | -1.4% | 181,900 |
2020/06/26 | 2,879 | 2,896 | 2,851 | 2,882 | +42 | +1.5% | 172,600 |
2020/06/25 | 2,816 | 2,851 | 2,788 | 2,840 | -2 | -0.1% | 273,800 |
2020/06/24 | 2,882 | 2,882 | 2,839 | 2,842 | -63 | -2.2% | 172,200 |
2020/06/23 | 2,912 | 2,920 | 2,850 | 2,905 | +6 | +0.2% | 164,600 |
2020/06/22 | 2,902 | 2,927 | 2,883 | 2,899 | +10 | +0.3% | 98,900 |
2020/06/19 | 2,911 | 2,911 | 2,854 | 2,889 | -23 | -0.8% | 450,900 |
2020/06/18 | 2,917 | 2,929 | 2,897 | 2,912 | +5 | +0.2% | 147,500 |
2020/06/17 | 2,915 | 2,934 | 2,906 | 2,907 | +10 | +0.3% | 151,900 |
2020/06/16 | 2,863 | 2,913 | 2,834 | 2,897 | +26 | +0.9% | 290,700 |
2020/06/15 | 2,827 | 2,937 | 2,825 | 2,871 | +20 | +0.7% | 215,600 |
2020/06/12 | 2,873 | 2,900 | 2,841 | 2,851 | -89 | -3% | 261,900 |
2020/06/11 | 2,923 | 2,960 | 2,922 | 2,940 | +10 | +0.3% | 136,100 |
2020/06/10 | 2,920 | 2,941 | 2,905 | 2,930 | -9 | -0.3% | 162,000 |
2020/06/09 | 2,955 | 2,964 | 2,938 | 2,939 | +6 | +0.2% | 156,800 |
1151~
1200
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム